Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Battelle and Nanotherapeutics Form Alliance to Accelerate Medical Countermeasures Development CBRNE April 5, 2017 …
Developing Cellular Therapies for Treatment of Radiation Injuries Contracts + Grants March 30, 2017 …
Medical Countermeasure Nonclinical Studies Network Contract Awards Contracts + Grants March 30, 2017 …
Princeton Researchers Develop Yellow Fever Virus Replication Tracking Technique Medical Countermeasures March 21, 2017 …
2009 Pandemic Flu Vaccine Strategy Worked, But Effectiveness Varied By Age Group Featured News March 14, 2017 …
PHEMCE Review: Accomplishments and Future Areas of Opportunity Antimicrobial Resistance March 2, 2017 …
BARDA Conducting Market Research on Ebola Medical Countermeasures Contracts + Grants February 23, 2017 …
Emergent BioSolutions to Develop Viral Hemorrhagic Fever Therapeutics Under BARDA Contract Featured News February 16, 2017 …
New Method Enables Rapid testing of Nanoparticles for Countermeasure Delivery Medical Countermeasures February 7, 2017 …
RFP – Nonhuman Primate Virology Laboratory for AIDS Vaccine Research Contracts + Grants February 6, 2017 …
Elusys Delivers Anthrax Countermeasure Order, Gains Funding for Lyophilization Effort Contracts + Grants February 2, 2017 …
